chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a licensed practical  nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 28-JUL-2016, the patient was vaccinated with improperly stored dose of VARIVAX (dose, route of administration and injection site were not provided)(lot # M009765, expiration date: 25-FEB-2018). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Shot was given too high, into shoulder joint.  Burning when given, pain down to elbow.  General soreness following week.  10 days after severe sharp shooting pain began, weakness, burning.  Treated with anti-inflammatory, MRI showed bone marrow edema and bursitis.  4 months later, shoulder still sore.  This is due to an improper injection, into the joint instead of the muscle.  Shot was given at work through by Occupational Health nurse.  Two others have the same issues.
This spontaneous report as received from a registered nurse (R.N.) refers to a patient of unknown age in her area (not from her office). On an unknown date the patient was vaccinated with PNEUMOVAX 23 (lot # not reported). The nurse heard that the patient developed flu like symptoms, rash and cellulitis after receiving PNEUMOVAX 23. The patient was hospitalized. It was unspecified whether the patient sought for medical attention. The nurse had no information on the patient. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Started Thursday after vaccination on Tuesday: Extreme fatigue. Head felt "full" "foggy". Nausea. Sweats. But worse was vertigo at night when turning over in bed. Lasted for 4-5 days.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 29-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
102.4 fever, body aches from the back of my neck to the back of my ankles, fatigue, throbbing migraine, no appetite
UrticariaPruritus, HYPERtension, site red, swollen, itchy; heaviness when breathing; elevate BP Day 10 - site is red, swollen, and itchy, heaviness when breathing, elevated BP from baseline; informed to follow-up w PCP
No menstrual cycle. Late which is highly unusual by more than 2 weeks. I experience cramps, insomnia, emotional imbalances essentially PMS but no actual bleeding.
Patient was given a dose of Rotarix on an unknown date but it was documented as Rotateq; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect information in patient's record in a patient who received Rota (Rotarix lyophilized formulation) for prophylaxis.   On an unknown date, the patient received the 1st dose of Rotarix lyophilized formulation. On an unknown date, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced incorrect information in patient's record (Verbatim: Patient was given a dose of Rotarix on an unknown date but it was documented as Rotateq). The outcome of the incorrect information in patient's record was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-MAY-2023 The reporter was medical assistant. The reporter reported that a patient was given a dose of Rotarix on an unknown date, but it was documented as Rotateq.  Then on 25th April 2023, the patient received a 2nd dose of Rotarix.  No symptoms were reported.  The healthcare professional did not have patient details, lot number or expiration date at the time of reporting. The call was disconnected before consent or clinic of where the vaccine was administered, could be confirmed. The patient was given a dose of Rotarix, but it was documented as Rotateq which led to Incorrect information in patient's record.
INTERMITTENT RAPID HEARTBEAT AND NOTICE MORE HEART BEATS WHILE SITTING; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergies, non-alcoholic, and non-smoker, and other pre-existing medical conditions included patient had no drug abuse or illicit drug usage. Patient was pretty health and does not take any medication. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 01-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 02-JUN-2021, the subject experienced intermittent rapid heartbeat and notice more heart beats while sitting. Laboratory data included: Heart rate (NR: not provided) intermittent rapid heart beat. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from intermittent rapid heartbeat and notice more heart beats while sitting. This report was non-serious.
Within 24 hours of the vaccine she became very irritable and her bowel movements stopped. Her belly became distended over time. It took 6 days for her to have a bowel movement after the vaccine. Her first bowel movement was extreme diarrhea, Since February 10th her bowel movements have been irregular and only diarrhea with her struggling to pass the movements, sometimes displaying signs of pain. She now needs assistance to pass gas and have bowel movements by supplements to her diet and exercising/massaging her abdominal area.
PT'S LEFT ARM STARTED TO HURT FRIDAY NIGHT AND BY SATURDAY THE PAIN WAS VERY SEVERE. ARM WAS SWOLLEN AND PT WAS UNABLE TO MOVE HER ARM MUCH. PT STARTED WITH A FEVER YESTERDAY. PT WAS SEEN IN OUR OFFICE TODAY. HER LEFT ARM IS SLOWLY GETTING BETTER. SWELLING HAS DECREASED AND PT HAS REGAINED MOBILITY. PT WAS STILL FEBRILE (99.9). PT WAS DIAGNOSED WITH POSTVACCINATION FEVER AND INSTRUCTED TO CONTINUE WITH SYMPTOMATIC CARE (HEAT, ICE, IBUPROFEN FOR AT LEAST 24 HRS). PT INSTRUCTED TO CALL BACK IF CONDITION WORSENS.
patient received extra dose of Hep B vaccine--patient had no adverse reaction noted; no treatment needed;  Health Dept notified and stated no side effects would be expected and that it will not harm him
This is a spontaneous report from a contactable consumer and follow-up from a contactable physician.  A 53-year-old female patient of an unspecified ethnicity received PREVNAR 13; (Lot Number: M73332; Expiration Date: Jul2017; Batch Number: 0000609988), subcutaneous in the left side of the abdomen on 01Oct2016 at 10:00 at a single dose for immunization.  The patient's medical history and concomitant medications were not reported.  On 01Oct2016, the patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) via subcutaneous injection in the left side of the abdomen instead of receiving PROLIA.  On an unknown date in Oct2016, the patient experienced cellulitis and injection site induration. The events did not require an emergency room or physician visit. The events also did not require hospitalization. Therapeutic measures were taken in response to the events and included treatment with unspecified medications. The clinical outcome of the events, patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) via subcutaneous injection in the left side of the abdomen instead of receiving denosumab, cellulitis, and injection site induration, was recovered with sequelae on unknown dates in Oct2016. The physician stated that the events, cellulitis and injection site induration, were causally related to the pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) as it was injected at the wrong site. Follow-up (28Oct2016): New information received from a contactable physician includes: patient demographics, suspect product data (added co-suspect denosumab); reaction data (added new events; cellulitis and injection site induration), outcome (recovered with sequelae), and causality (related).
Muscle pain; Metallic taste; Diarrhea; Gas; Itching; Dizziness; Swelling; 100.4 degree fever; Vomiting; Nausea; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste), DIARRHOEA (Diarrhea), FLATULENCE (Gas), PRURITUS (Itching) and DIZZINESS (Dizziness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste), DIARRHOEA (Diarrhea), FLATULENCE (Gas), PRURITUS (Itching), DIZZINESS (Dizziness), SWELLING (Swelling), PYREXIA (100.4 degree fever), VOMITING (Vomiting), NAUSEA (Nausea) and VACCINATION SITE PAIN (Sore arm). On an unknown date, the patient experienced MYALGIA (Muscle pain). At the time of the report, DYSGEUSIA (Metallic taste), DIARRHOEA (Diarrhea), FLATULENCE (Gas), PRURITUS (Itching), DIZZINESS (Dizziness), SWELLING (Swelling), PYREXIA (100.4 degree fever), VOMITING (Vomiting), NAUSEA (Nausea), VACCINATION SITE PAIN (Sore arm) and MYALGIA (Muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 100.4 (High) 100.4 degree fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included IV fluids , pain killers.   Most recent FOLLOW-UP information incorporated above includes: On 18-Mar-2021: No specific follow-up information recorded. On 23-Jun-2021: Follow-up information received on 23-JUN-2021 contains no new information.
Severly red, swollen, a lot of pain, very bad itching, went to my doctor on 05/18/2016, diagnosis, left arm cellulitis, bad infection, hot to touch, hot and cold chills, arm is throbbing, red, itching, and hurts, was put on strong antibiotics, Tylenol, and Benadryl for itching.
Dermographia began on 12 days after receiving the booster shot. Began with intense skin itching every where. Upon touching or scratching the skin, it will turn red, get swollen, and either burn or itch very intensely. Hives also sometimes show up depending on the location (inner thighs, back of the neck, arms, etc.) The reaction has been happening since and is constant, except during sleep or meditation.
One day post vax pt developed abscess to left deltoid area, and was evaluated in ER. Pt seen in physician's office 5 days post vax and given a prescription for Abx.
Had what looked to be a superficial blood cot  right under the skin on my right hand, in the soft flesh right above my thumb joint. It was purple, enlarged and painful. It lasted 2 days, then went down in size and turned purplish brown like an older bruise. I did not injure myself there. My husband had a similar thing happen before mine, about a week before.  He had a purplish raised vein also at the base of his small finger and his finger was numb. It also went away within a few days.
Intense swelling of upper arm slowing moving down the arm to the elbow and forearm. Severe muscle ache. Redness and inflammation on inside of bicep. I was told to apply ice to keep swelling down. One week later, swelling is reduced along with ache. Inflammation is beginning to go away.
PATIENT CALLED PHARMACY 2 DAYS LATER COMPLAINING OF RASH ON OPPOSITE ARM THAT SHE RECEIVED IMMUNIZATION.  SHE DESCRIBED THE RASH AS RED AND CIRCULAR, AND ITCHY (BUT NOT RINGWORM).  INSTRUCTED PATIENT TO USE OTC AIDS (HYDROCORTISONE CREAM) AND GO TO URGENT CARE/EMERGENCY IF RASH ESCALATES.
gout; electrical radiation went up her leg\ waking up to right toe being in excruciating pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GOUT (gout) and PAIN (electrical radiation went up her leg\ waking up to right toe being in excruciating pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GOUT (gout) and PAIN (electrical radiation went up her leg\ waking up to right toe being in excruciating pain). At the time of the report, GOUT (gout) and PAIN (electrical radiation went up her leg\ waking up to right toe being in excruciating pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment products were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-096435 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-096435:
Pt was a check out and passed out. She fell backward and hit her head on door frame. Her eyes rolled back and she started to shake for 20 seconds.
Lymph node in shoulder area same side vaccine administered (Left deltoid) became swollen accompanied with pain when moving left arm, several hours after injection, no other symptoms presented.  Client had Tdap administered three weeks prior by private provider that also became swollen but with much less pain.  Current symptom was decreasing at time notified provider.
I developed shingles approximately 2 weeks after getting the first dose of the shingles vaccine.
Pt in clinic. Clinic went to administer Hep A and COVID vaccine. Pt stated he needed to receive his second dose of Hep A vaccine and received a dose of Hep A vaccine on 09/17/2021. Upon further evaluation, patient has received pediatric doses of Hep A on 10/29/2010 and 06/07/2013. Pt had also received an adult dose of Hep A on 11/26/2019. RN went to center to notify patient of receiving 4 doses. No adverse events noted.
On 6/12/01, child received the below mentioned immunizations at approx. 14:00. Was given several doses of cherry flavored Tylenol (which was not given before). On 6/13/01, the grandma noticed red non-raised rash on neck, chest and legs. Grandma took child to doctor on 6/13/01. No treatment given. Doctor unsure if it was vaccine related. On 6/14/01, rash gone.
Severe muscle pain to the point of tears for about 8-10 hours even after extra strength tylenol.  Temp 101.6 after extra strength tylenol. Severe fatigue, muscle weakness-could not get out of the bed or even sit upright in the bed for nearly 72 hours.  Once the pain subsided, body aches, weakness and tingling began, mostly located in lower extremities and gluteal muscles.  Yesterday, day, 4, weakness/tingling/feeling of electrical impulses throughout lower extremities which was intermittent.  I am currently on day 5 now and still experiencing fatigue, aches/feeling of impulses throughout lower extremities intermittently.  I have a Dr. appointment scheduled for tomorrow 2/4/2021
Patient was given booster dose 3.5 months after second dose , in error.  Patient reports fatigue and achiness today, 24 hours after shot administration.
had the 2nd dose on March 23rd and has been experiencing flu-like symptoms without fever since yesterday; This is a spontaneous report from a Pfizer-sponsored  via a contactable female consumer (patient). A female patient of an unspecified age received bnt162b2 (Pfizer Covid-19 Vaccine), dose 2 via an unspecified route of administration on 23Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 on 28Feb2021 for COVID-19 immunisation and experienced headache. The patient had the 2nd dose on 23Mar2021 and has been experiencing flu-like symptoms without fever since yesterday on 06Apr2021. The patient took Tylenol. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report was received from a consumer and refers to his father, a male patient of unknown age. There was no information about patient's medical history, drug reactions or allergies provided. On 15-AUG-2015, the patient was vaccinated with ZOSTAVAX (lot #, expiration date, dose, site and route of administration were not reported); PNEUMOVAX23 (lot #, expiration date, dose, site and route of administration were not reported) and influenza virus vaccine (unspecified). In August 2015, the patient experienced a fever of 102 degrees within 24 hours of receiving vaccinations. The patient took MOTRIN and rested as home treatment. The patient recovered from the event (date unspecified). The relatedness between the event and ZOSTAVAX, PNEUMOVAX23, influenza virus vaccine (unspecified) was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Appear to be either Shingles or hives, itchy spots on neck face and scalp; Appear to be either Shingles or hives, itchy spots on neck face and scalp; Appear to be either Shingles or hives, itchy spots on neck face and scalp; This is a spontaneous report from a contactable consumer (patient). A 46-years-old female patient received dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EL9265), via an unspecified route of administration in left arm on 05Feb2021 10:30 at single dose for COVID-19 immunization. Medical history included Allergic to shellfish, Allergic to soy, Mould allergy, pollen allergies, Atopic dermatitis. There were no concomitant medications. The patient previously took dupilumab (DUPIXENT) from unknown date to 20Dec2020 for Atopic dermatitis. The patient experienced appear to be either shingles or hives, itchy spots on neck face and scalp on 06Feb2021 06:00. Treatment received for the events included Desoxymetasone steroid applied without any effect. The patient was not pregnant. The patient had no COVID prior vaccination. She had no COVID tested post vaccination. There was no other vaccine received at the same date of the COVID-19 vaccine. There was no other vaccine received in four weeks. The outcome of the events was not recovered.
Blood Clots in both little toes. Eliquis 5 mg, Gabapentin 300 mg, Tramadol 50 mg.
FELT WEAK FIRST. VERY TIRED. WENT TO BED & WOKE TO BURNING PAIN ALL OVER BODY. MIGRAINE. ARM PAIN FROM SHOT OVER SHOULDERS TO OTHER ARM -WEAK ARM & PAIN. [NEXT DAY-6/25/15] TIRED ALL DAY. COULDN'T EAT, DIARRHEA ALL DAY. FRIDAY SAME BUT FELT ITCHING, FLU LIKE SYMPTOMS. CALLED DOCTOR OFFICE BEFORE THEY CLOSED ON FRI 6/26/15. STATING I HAD A PAIN LIKE PINCHED RIB. OVER THE NIGHT INTO SATURDAY THIS GOT WORSE. WHEN I WOKE UP SATURDAY 11 A.M. AFTER HARDLY ANY SLEEP I CALLED DOCTORS OFFICE IMMEDIATELY & WAS TOLD TO GO TO ER IMMEDIATELY. I COULDN'T BREATHE ENOUGH WITHOUT SHARP PAIN & PRESSURE IN RT. RIB. FELT SWOLLEN ALL OVER.
Existing areas of psoriasis became hot and red around and in and itched and burned. Sunday, there were itchy bumps and the psoriasis was oozing clear liquid that scabbed over. Monday, went to doctor and was put on Methylprednisolone tablets for the acute reaction.
Pt. was given H1N1 vaccination on Jan 27, 2010. But didn't get the full body rash until ~March 11, 2010. Macular Papula rash from face, arms, trunk visually apparent to me.
A Moderna bivalent vaccination was given one day after determined BUD. BUD was 8/28 and was given 8/29; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccination was given one day after determined BUD. BUD was 8/28 and was given 8/29) and NO ADVERSE EVENT (no adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Aug-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Aug-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccination was given one day after determined BUD. BUD was 8/28 and was given 8/29) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccination was given one day after determined BUD. BUD was 8/28 and was given 8/29) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccination was given one day after determined BUD. BUD was 8/28 and was given 8/29).    No concomitant medication information was reported. BUD was 28-Aug-2023. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Aug-2023: Live follow up has been appended.
Before receiving the 3rd dose of covid vaccine, I was recovering from Pityarisis rosea (diagnosed on 08/05/2021); all lesions were improving by using steroid ointment BID. approximately 2 weeks after receiving the Covid 19 booster, the rash worsened: lesions increased in size, extremely itchy, also painful. Lesions were on left forearm and arm, right wrist, left breast, both buttocks, left thigh, and behind right knee. Saw dermatologist on 09/30/2021 who noticed the "new" rash lesions were different from the pityriasis rosea rash and suspected a viral exanthema related to administration of covid 19 booster.